| COVID-19 | Coronavirus-induced disease 2019 |
| CPIC | Clinical Pharmacogenetics Implementation Consortium |
| DDI | Drug–drug interaction |
| FDA | U.S. Food and Drug Administration |
| HCC | Hierarchical conditions category |
| LOS | Length of stay |
| PIP | Pharmacogenetic interaction probability |
| RAF | Risk adjustment factor |
| SNP | Special needs plan |